총 39 건의 최근 내부자 거래 내역가 기록되었습니다 Elicio Therapeutics, Inc. (ELTX), 포함 34 건 매수 및 4 건 매도. 내부자 매수 총액은 $26.63M 내부자 매도 총액은 $20M.
최근 활동이 있는 주요 내부자에는 Haqq Christopher, Shah Preetam, Connelly Robert. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — ELTX
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2026-02-02 |
Haqq Christopher |
See Remarks |
RSU 부여 |
50,900 |
$8.10 |
$412.29K |
50,900 |
| 2026-02-02 |
Shah Preetam |
See Remarks |
RSU 부여 |
24,000 |
- |
- |
24,000 |
| 2026-02-02 |
Connelly Robert |
CEO, President and Director |
RSU 부여 |
73,600 |
- |
- |
120,570 |
| 2026-02-02 |
Demuth Peter |
Chief Scientific Officer |
RSU 부여 |
20,800 |
- |
- |
21,543 |
| 2025-12-09 |
Demuth Peter |
Chief Scientific Officer |
옵션 행사 (매도) |
362 |
$4.41 |
$1.6K |
- |
| 2025-06-03 |
Chudnovsky Yekaterina |
10 Percent Owner |
RSU 부여 |
103,225 |
$7.75 |
$799.99K |
103,225 |
| 2025-05-19 |
Ruffolo Robert R |
Director |
RSU 부여 |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Adams Julian |
Director |
RSU 부여 |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Wilson Karen J |
Director |
RSU 부여 |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Venkatesan Jay |
Director |
RSU 부여 |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Nissenson Allen |
Director |
RSU 부여 |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Ashe Carol Gail |
Director |
RSU 부여 |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-05-19 |
Chudnovsky Yekaterina |
10 Percent Owner |
RSU 부여 |
7,900 |
$5.84 |
$46.14K |
7,900 |
| 2025-04-15 |
Shah Preetam |
See Remarks |
RSU 부여 |
191,624 |
$4.98 |
$954.29K |
191,624 |
| 2025-03-24 |
Shah Preetam |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2025-03-05 |
Chudnovsky Yekaterina |
10 Percent Owner |
전환 (매도) |
3,442,341 |
$5.81 |
$20M |
- |
| 2025-02-03 |
Haqq Christopher |
See Remarks |
RSU 부여 |
44,000 |
$8.92 |
$392.48K |
44,000 |
| 2025-02-03 |
Connelly Robert |
CEO, President and Director |
RSU 부여 |
121,600 |
$8.92 |
$1.08M |
121,600 |
| 2025-02-03 |
Demuth Peter |
Chief Scientific Officer |
RSU 부여 |
44,400 |
$8.92 |
$396.05K |
44,400 |
| 2024-12-16 |
Demuth Peter |
Chief Scientific Officer |
옵션 행사 (매도) |
381 |
$4.41 |
$1.68K |
- |
| 2024-11-26 |
Venkatesan Jay |
Director |
옵션 행사 (ITM) |
50,000 |
$0.01 |
$500.00 |
- |
| 2024-11-21 |
Ruffolo Robert R |
Director |
RSU 부여 |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Adams Julian |
Director |
RSU 부여 |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Wilson Karen J |
Director |
RSU 부여 |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Venkatesan Jay |
Director |
RSU 부여 |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Nissenson Allen |
Director |
RSU 부여 |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Ashe Carol Gail |
Director |
RSU 부여 |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-11-21 |
Chudnovsky Yekaterina |
10 Percent Owner |
RSU 부여 |
4,100 |
$5.12 |
$20.99K |
4,100 |
| 2024-09-30 |
Haqq Christopher |
See Remarks |
RSU 부여 |
28,200 |
$5.03 |
$141.85K |
28,200 |
| 2024-09-30 |
Connelly Robert |
CEO, President and Director |
RSU 부여 |
91,600 |
$5.03 |
$460.75K |
91,600 |
| 2024-09-30 |
Demuth Peter |
Chief Scientific Officer |
RSU 부여 |
29,800 |
$5.03 |
$149.89K |
29,800 |
| 2024-08-12 |
Chudnovsky Yekaterina |
10 Percent Owner |
정보 매수 |
3,442,341 |
$5.81 |
$20M |
3,442,341 |
| 2024-06-28 |
Venkatesan Jay |
Director |
정보 매수 |
50,000 |
$0.01 |
$500.00 |
50,000 |
| 2024-06-28 |
Chudnovsky Yekaterina |
10 Percent Owner |
정보 매수 |
1,600,000 |
$0.01 |
$16K |
1,600,000 |
| 2024-03-19 |
Chudnovsky Yekaterina |
10 Percent Owner |
정보 매수 |
1,032,702 |
$0.01 |
$10.33K |
1,032,702 |
| 2024-02-01 |
Haqq Christopher |
See Remarks |
RSU 부여 |
28,200 |
$4.50 |
$126.9K |
28,200 |
| 2024-02-01 |
Connelly Robert |
CEO, President and Director |
RSU 부여 |
225,137 |
$4.50 |
$1.01M |
225,137 |
| 2024-02-01 |
Piekos Brian |
Chief Financial Officer |
RSU 부여 |
43,225 |
$4.50 |
$194.51K |
43,225 |
| 2024-02-01 |
Demuth Peter |
Chief Scientific Officer |
RSU 부여 |
342 |
$4.50 |
$1.54K |
342 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
